Singapore, May 17 -- Thermo Fisher recently celebrated the opening of its new Cell and Gene Therapy (CGT) Vision Centre in South Korea. The centre is part of the company's growing global network dedicated to supporting its customers and accelerating the development of personalised treatments. "The CGT field is driving breakthroughs in treating rare and intractable diseases, advancing personalised medicine and shaping the future of regenerative medicine," said Thermo Fisher's Soo Jin Seok. "These innovations require highly specialised support from discovery through commercialisation. With the launch of the CGT Vision Centre, we will empower our customers with access to cutting-edge technologies, regulatory expertise and end-to-end workflow...